Cellebrite DI (CLBT) Total Liabilities (2020 - 2026)

Cellebrite DI has reported Total Liabilities for 7 years, with the latest figure at $456.2 million in Q2 2026.

• On a quarterly basis, Total Liabilities rose 20.37% year-over-year to $456.2 million in Q2 2026; TTM through Jun 2026 was $456.2 million, a 20.37% increase from a year earlier, with the FY2025 full-year figure at $454.5 million, up 28.2% from the prior year.
• Total Liabilities was $456.2 million for Q2 2026 at Cellebrite DI, up from $441.7 million in the prior quarter.
• The five-year high for Total Liabilities was $596.7 million in Q2 2024, with the low at $293.0 million in Q3 2022.
• Average Total Liabilities over 5 years is $404.6 million, with a median of $382.8 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities surged 487.77% in 2022, then sank 37.68% in 2025.
• Over 5 years, Total Liabilities stood at $329.4 million in 2022, then jumped by 51.38% to $498.7 million in 2023, then slipped by 28.9% to $354.5 million in 2024, then rose by 28.2% to $454.5 million in 2025, then rose by 0.37% to $456.2 million in 2026.
• The last three Total Liabilities figures came in at $456.2 million (Q2 2026), $441.7 million (Q1 2026), and $454.5 million (Q4 2025), per Business Quant data.